Three probiotic strains derived from healthy human gut microflora to help maintain cholesterol levels in a normal, healthy range.
Probiotics for cardiometabolic health
Cardiometabolic health
Healthy gut, happy heart
Science shows that the gut bacteria may influence several molecules linked to lipid metabolism, which is closely linked to cholesterol 1,2,3,4
We have characterized the mechanism of action in our probiotic solutions to deliver targeted cardiometabolic health solutions – proven to support healthy cholesterol and safe weight management.
Probiotic solutions for Cardiometabolic health
KABP® Cardio
1.2 billion CFU/dose
Indications
- Promotes heart health
- Supports healthy total cholesterol, LDL and HDL levels already in the normal range
- Helps maintain cholesterol levels already in the normal range in healthy individuals
- Maintains a healthy triglyceride level already in the normal range
- FDA GRAS certified
Probiotic Strains
- L. plantarum KABP® 011
- L. plantarum KABP® 012
- L. plantarum KABP® 013
Formats
Capsules, sticks, drops
Clinical Evidence
Tang, W. H. W., Kitai, T. & Hazen, S. L. Gut microbiota in cardiovascular health and disease. Circulation Research vol. 120 1183–1196 (2017).
Herrema, H, Nieuwdorp, M. & Groen, A. K. Microbiome and Cardiovascular Disease. Handb Exp Pharmacol (2020).
Karlsson, F. H. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, (2012).
Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: Human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
Dora IA et al. “Effects of Consumption of Probiotics and Prebiotics on Serum Lipid Levels in Humans”. Critical Reviews in Biochemistry and Molecular Biology 37(4) (2002), 259- 281.
Fuentes, Mari C., et al. “Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults.” British Journal of Nutrition 109.10 (2013): 1866-1872.
Fuentes, Mari C., et al. “A randomized clinical trial evaluating a proprietary mixture of Lactobacillus plantarum strains for lowering cholesterol1.” Mediterranean Journal of Nutrition and Metabolism, vol. 9, no. 2, pp. 125-135, 2016.
Jumangit, et al. “An observational, prospective study to determinate the efficacy and safety of AB-LIFE.” Poster presentation.
Tang, W. H. W., Kitai, T. & Hazen, S. L. Gut microbiota in cardiovascular health and disease. Circulation Research vol. 120 1183–1196 (2017).
Herrema, H, Nieuwdorp, M. & Groen, A. K. Microbiome and Cardiovascular Disease. Handb Exp Pharmacol (2020).
Karlsson, F. H. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, (2012).
Request our Products Brochure by filling out the form below
Would you like to know more about our products?
